Avid Bioservices Inc (CDMO)

[entdoc]

drrock, thanks.IR report mirrors my thinking. Koman, please elaborate on, "There won't be a partner for it [Cotara]because pharmas don't want to deal w/ a radio-labeled antibody therapy."
I don't think radio-labeled antibodies are a problem for provider or patient if they do the job. One problem with the Cotara GBM brain cancer trial is, why do you need a monoclonal antibody (Cotara) to deliver the RAI if you are delivering it directly into tumor with a special catheter? A study to answer that question would be difficult.